3805 OLD EASTON ROAD, DOYLESTOWN, PA
Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051
Investor Presentation
Reports Second Quarter 2025 Financial Results and Provides a Clinical Update
Submission of Matters to a Vote of Security Holders
Reports First Quarter 2025 Financial Results and Provides a Clinical Update
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload